Table II.
Characteristic | Main duct-type IPMN (n=33) | Branch duct-type IPMN (n=67) | P-value |
---|---|---|---|
Tumor marker, blood chemistry | |||
Carcinoembryonic antigen (ng/ml) | 3.0±3.0 | 2.7±2.1 | 0.566 |
Carbohydrate antigen 19–9 (U/ml) | 55.5±88.0 | 48.1±182.7 | 0.850 |
Surgical period | |||
Immediately (%) | 81.8 | 53.7 | 0.027 |
Follow-up (%) | 18.2 | 46.3 | |
Follow-up, median years (range) | 1.6 (1–2) | 3.6 (1–10) | 0.021 |
Surgical procedure (n) | |||
Total pancreatectomy | 4 | 2 | 0.143 |
Pancreaticoduodenectomy | 17 | 31 | |
Distal pancreatectomy | 10 | 24 | |
Minimal invasive surgery | 0 | 10 | |
Pathology | |||
Adenoma | 10 | 55 | |
Non-invasive carcinoma | 14 | 3 | 0.001 |
Invasive carcinoma | 9 | 9 |
IPMN, intraductal papillary mucinous neoplasm.